ORDERMED LIMITED
Company number 13264655 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
ORDERMED LIMITED - Analysis Report
Company Number: 13264655
Analysis Date: 2025-07-20 18:48 UTC
Financial Health Score: A
Key Vital Signs:
- Company Status: Active, not in liquidation or administration—indicates operational continuity.
- Account Category: Dormant for the latest financial year—no trading activity or financial transactions.
- Share Capital: £24,000,000 fully paid—strong equity base.
- Net Assets / Shareholders Funds: £24,000,000 unchanged over four years—stable balance sheet with no liabilities or operational losses.
- Filing Compliance: Accounts and confirmation statements filed on time—good regulatory discipline.
- Director Stability: Single director appointed at incorporation, with no changes or disqualifications—steady governance.
- Industry Classification: Web portals (SIC 63120)—potential for digital business but currently not active.
Symptoms Analysis:
The company’s financial “vital signs” reveal a very particular condition: ORDERMED LIMITED has maintained a dormant status since inception, meaning it has had no significant trading activity or financial transactions. This is analogous to a patient in a stable but inactive state—no signs of financial distress such as debt, losses, or cash flow problems.
The large, fully paid share capital of £24 million acts like a substantial financial “reserve,” akin to a healthy bank of nutrients in the body, providing strong backing and flexibility for future operations. Since net assets are equal to shareholders’ funds and remain steady, it suggests no liabilities or hidden financial burdens—this is a clean and robust balance sheet.
The punctual filing of accounts and confirmation statements indicates good “administrative health,” avoiding penalties or regulatory complications. The presence of only one director, with no adverse records, implies a stable governance environment, though the lack of operational activity might also suggest a dormant or holding company role.
Diagnosis:
ORDERMED LIMITED is currently in a dormant financial condition. Its balance sheet is exceptionally strong with no liabilities and significant equity capital, suggesting it is well-positioned to commence trading or other business activities without immediate financial risk.
However, the company is not generating revenue, incurring expenses, or engaging in operational activities at present. This “inactivity” could be strategic (e.g., holding company, awaiting market conditions) or due to other business reasons.
From a financial health perspective, there are no symptoms of distress—no debts, no losses, no cash flow issues. The company is effectively in a state of financial hibernation, ready to “wake up” and deploy its resources when needed.
Prognosis:
Given the strong equity base and clean dormant status, the company has an excellent prognosis for future financial health upon activation of business activities. The key will be managing the transition from dormancy to active trading carefully, ensuring that operational costs, cash flow, and profitability are monitored as the business scales.
The company should be cautious to maintain compliance and avoid unnecessary expenditures during dormancy. If the business plans to start trading, it should prepare for typical “growing pains” such as working capital management and potential initial losses.
Recommendations:
Assess Business Strategy: Clarify the company’s operational plan and timeline to move from dormant to active status. If the company is a holding vehicle, ensure proper management of subsidiary investments and legal compliance.
Maintain Compliance: Continue timely filing of dormant accounts and confirmation statements to avoid penalties and preserve good standing.
Prepare Financial Controls: Before commencing trading, establish robust financial management systems for cash flow monitoring, budgeting, and cost control to prevent “symptoms of financial distress” during startup phase.
Review Capital Utilization: Evaluate whether the large share capital (£24 million) is optimally structured and whether it can be leveraged for investment or financing needs without risking shareholder dilution.
Governance: Consider expanding director or management expertise if transitioning to active operations to provide broader oversight and strategic guidance.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.